Garath Duffy serves as Director of Supply Chain and Project Management at Vetter’s clinical manufacturing facility in Rankweil, Austria. He is an expert in transitioning injectable medications from preclinical to clinical development, with extensive experience supporting biotech companies during the early-phase development of a wide range of molecules. As a leader at Vetter Clinical Development Service, he has helped many of these organizations navigate the critical pivot from lab to in-human trials.
Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than 5,700 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.